首页> 外文OA文献 >Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT

【2h】

Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT

机译：早期生物标志物与放射治疗前列腺癌患者的继发性原发癌风险相关：ImRT与ImaT

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Werbrouck Joke; Ost Piet; FONTEYNE VALERIE; De Meerleer Gert; De Neve Wilfried; Bogaert Evelien; Beels Laurence; Bacher Klaus; Vral Anne; Thierens Hubert;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT [J] . WerbrouckJ., OstP., FonteyneV., Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2013,第3期

机译：与放射治疗的前列腺癌患者继发原发癌风险相关的早期生物标志物：IMRT与IMAT
2. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT [J] . Boram Lee, Sunyoung Lee, Jiwon Sung, Journal of radiological protection: Official journal of the Society for Radiological Protection . 2014,第2期

机译：放射线治疗引起的继发性乳腺癌风险：3D适形疗法，IMRT，VMAT
3. Three‐month posttreatment prostate‐specific antigen level as a biomarker of treatment response in patients with intermediate‐risk or high‐risk prostate cancer treated with androgen deprivation therapy and radiotherapy [J] . Bryant Alex K., DAmico Anthony V., Nguyen Paul L., Cancer: A Journal of the American Cancer Society . 2018,第14期

机译：三个月的后前列腺特异性抗原水平作为患有雄激素剥夺治疗和放射治疗的中间风险或高风险前列腺癌的患者治疗反应的生物标志物
4. The Risk for Secondary Cancers in Patients Treated for Prostate Carcinoma - An Analysis with the Competition Dose Response Model [C] . A. Dasu, I. Toma-Dasu, L. Franzen, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：前列腺癌患者继发癌症的风险-竞争剂量反应模型的分析
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy [O] . Nigel P Murray, Socrates Aedo, Cynthia Fuentealba, 2018

机译：二级循环前列腺肿瘤细胞的存在决定了仅接受外部放射治疗的低危和中危前列腺癌患者生化复发的风险
7. Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT [O] . Werbrouck Joke, Ost Piet, Fonteyne Valerie, 2013

机译：与放射治疗的前列腺癌患者继发原发癌风险相关的早期生物标志物：IMRT与IMAT

Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT

著录项

相似文献

相关主题

期刊订阅